 |
|
Phase III Adjuvant Chemotherapy with Intensive CEF (CTX/EPI/5-FU) vs Standard CMF (CTX/MTX/5-FU) in Premenopausal Patients with Carcinoma of the Breast with Positive Axillary Nodes
Basic Trial Information
Trial Contact Information
Basic Trial Information
| Phase | Type | Status | Age | Protocol IDs |
|---|
| Phase III | Treatment | Closed | pre/perimenopausal | CAN-NCIC-MA5
NCI-V90-0027, MA5 |
Trial Contact Information
Trial Lead Organizations NCIC-Clinical Trials Group | | | | Mark Levine, MD, Protocol chair(Contact information may not be current) | | | Ph: 905-527-4322 ext. 42176 |
| |
Back to Top |
|
